Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Cocaine-induced toxic leucoencephalopathy with complete clinical recovery.

Abdilla Y, Cauchi M, Vella N.

BMJ Case Rep. 2019 Jul 27;12(7). pii: e229134. doi: 10.1136/bcr-2018-229134.

PMID:
31352378
2.

Anti-HMGCR antibody-associated necrotising myopathy and its association with statin use.

Abdilla Y, Chircop C, Vella N.

BMJ Case Rep. 2018 Nov 12;2018. pii: bcr-2018-226302. doi: 10.1136/bcr-2018-226302.

PMID:
30420560
3.

Sustaining a culture of practice development in an acute adolescent inpatient mental health unit.

Vella N, Page L, Edwards C, Wand T.

J Child Adolesc Psychiatr Nurs. 2017 Nov;30(4):195-200. doi: 10.1111/jcap.12194.

PMID:
30129245
4.

The use of geographic information system and 1860s cadastral data to model agricultural suitability before heavy mechanization. A case study from Malta.

Alberti G, Grima R, Vella NC.

PLoS One. 2018 Feb 7;13(2):e0192039. doi: 10.1371/journal.pone.0192039. eCollection 2018.

5.

The ultrastructure of spinal cord perivascular spaces: Implications for the circulation of cerebrospinal fluid.

Lam MA, Hemley SJ, Najafi E, Vella NGF, Bilston LE, Stoodley MA.

Sci Rep. 2017 Oct 10;7(1):12924. doi: 10.1038/s41598-017-13455-4.

6.

A molecular approach towards taxonomic identification of elasmobranch species from Maltese fisheries landings.

Vella A, Vella N, Schembri S.

Mar Genomics. 2017 Dec;36:17-23. doi: 10.1016/j.margen.2017.08.008. Epub 2017 Oct 3.

PMID:
28923557
7.

Population genetics of the deep-sea bluntnose sixgill shark, Hexanchus griseus, revealing spatial genetic heterogeneity.

Vella N, Vella A.

Mar Genomics. 2017 Dec;36:25-32. doi: 10.1016/j.margen.2017.05.012. Epub 2017 Jun 8.

PMID:
28602510
8.

Morphometry and microanatomy of the barbels of the common sawshark Pristiophorus cirratus (Pristiophoridae): implications for pristiophorid behaviour.

Nevatte RJ, Williamson JE, Vella NGF, Raoult V, Wueringer BE.

J Fish Biol. 2017 May;90(5):1906-1925. doi: 10.1111/jfb.13275. Epub 2017 Mar 17.

PMID:
28303565
9.

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry.

Rojas JI, Patrucco L, Trojano M, Lugaresi A, Izquierdo G, Butzkueven H, Jokubaitis V, Duquette P, Girard M, Grand'Maison F, Grammond P, Oreja-Guevara C, Hupperts R, Boz C, Petersen T, Bergamaschi R, Giuliani G, Lechner-Scott J, Barnett M, Rio ME, Van Pesch V, Amato MP, Iuliano G, Fiol M, Slee M, Verheul F, Fernandez-Bolanos R, Poehlau D, Saladino ML, Braber-Moerland LD, Deri N, Oleschko-Arruda W, Cabrera-Gomez JA, Paine M, Vella N, Kister I, Skromne E, Savino A, Shaw C, Moore F, Vucic S, Petkovska-Boskova T, Bacile EAB, Santiago V, Cristiano E.

Mult Scler J Exp Transl Clin. 2015 Aug 17;1:2055217315600193. doi: 10.1177/2055217315600193. eCollection 2015 Jan-Dec.

10.

Predictors of disability worsening in clinically isolated syndrome.

Jokubaitis VG, Spelman T, Kalincik T, Izquierdo G, Grand'Maison F, Duquette P, Girard M, Lugaresi A, Grammond P, Hupperts R, Cabrera-Gomez J, Oreja-Guevara C, Boz C, Giuliani G, Fernández-Bolaños R, Iuliano G, Lechner-Scott J, Verheul F, van Pesch V, Petkovska-Boskova T, Fiol M, Moore F, Cristiano E, Alroughani R, Bergamaschi R, Barnett M, Slee M, Vella N, Herbert J, Shaw C, Saladino ML, Amato MP, Liew D, Paolicelli D, Butzkueven H, Trojano M.

Ann Clin Transl Neurol. 2015 May;2(5):479-91. doi: 10.1002/acn3.187. Epub 2015 Mar 27.

11.

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

Spelman T, Gray O, Trojano M, Petersen T, Izquierdo G, Lugaresi A, Hupperts R, Bergamaschi R, Duquette P, Grammond P, Giuliani G, Boz C, Verheul F, Oreja-Guevara C, Barnett M, Grand'Maison F, Edite Rio M, Lechner-Scott J, Van Pesch V, Fernandez Bolanos R, Flechter S, Den Braber-Moerland L, Iuliano G, Amato MP, Slee M, Cristiano E, Saladino ML, Paine M, Vella N, Kasa K, Deri N, Herbert J, Moore F, Petkovska-Boskova T, Alroughani R, Savino A, Shaw C, Vucic S, Santiago V, Bacile EA, Skromne E, Poehlau D, Cabrera-Gomez JA, Lucas R, Butzkueven H.

Ann Neurol. 2014 Dec;76(6):880-90. doi: 10.1002/ana.24287. Epub 2014 Oct 20.

PMID:
25283272
12.

Magnetic properties of uncultivated magnetotactic bacteria and their contribution to a stratified estuary iron cycle.

Chen AP, Berounsky VM, Chan MK, Blackford MG, Cady C, Moskowitz BM, Kraal P, Lima EA, Kopp RE, Lumpkin GR, Weiss BP, Hesse P, Vella NG.

Nat Commun. 2014 Sep 1;5:4797. doi: 10.1038/ncomms5797.

PMID:
25175931
13.

Sustaining a culture of practice development in an acute adolescent inpatient mental health unit.

Vella N, Page L, Edwards C, Wand T.

J Child Adolesc Psychiatr Nurs. 2014 Aug;27(3):149-55. doi: 10.1111/jcap.12080.

PMID:
25103725
14.

Risk of relapse phenotype recurrence in multiple sclerosis.

Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, Girard M, Lugaresi A, Grammond P, Grand'Maison F, Oreja-Guevara C, Boz C, Hupperts R, Petersen T, Giuliani G, Iuliano G, Lechner-Scott J, Barnett M, Bergamaschi R, Van Pesch V, Amato MP, van Munster E, Fernandez-Bolanos R, Verheul F, Fiol M, Cristiano E, Slee M, Rio ME, Spitaleri D, Alroughani R, Gray O, Saladino ML, Flechter S, Herbert J, Cabrera-Gomez JA, Vella N, Paine M, Shaw C, Moore F, Vucic S, Savino A, Singhal B, Petkovska-Boskova T, Parratt J, Sirbu CA, Rozsa C, Liew D, Butzkueven H; MSBase Study Group.

Mult Scler. 2014 Oct;20(11):1511-22. doi: 10.1177/1352458514528762. Epub 2014 Apr 28.

PMID:
24777276
15.

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.

Kalincik T, Vivek V, Jokubaitis V, Lechner-Scott J, Trojano M, Izquierdo G, Lugaresi A, Grand'maison F, Hupperts R, Oreja-Guevara C, Bergamaschi R, Iuliano G, Alroughani R, Van Pesch V, Amato MP, Slee M, Verheul F, Fernandez-Bolanos R, Fiol M, Spitaleri DL, Cristiano E, Gray O, Cabrera-Gomez JA, Shaygannejad V, Herbert J, Vucic S, Needham M, Petkovska-Boskova T, Sirbu CA, Duquette P, Girard M, Grammond P, Boz C, Giuliani G, Rio ME, Barnett M, Flechter S, Moore F, Singhal B, Bacile EA, Saladino ML, Shaw C, Skromne E, Poehlau D, Vella N, Spelman T, Liew D, Kilpatrick TJ, Butzkueven H; MSBase Study Group.

Brain. 2013 Dec;136(Pt 12):3609-17. doi: 10.1093/brain/awt281. Epub 2013 Oct 18.

PMID:
24142147
16.

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Hughes SE, Spelman T, Gray OM, Boz C, Trojano M, Lugaresi A, Izquierdo G, Duquette P, Girard M, Grand'Maison F, Grammond P, Oreja-Guevara C, Hupperts R, Bergamaschi R, Giuliani G, Lechner-Scott J, Barnett M, Edite Rio M, van Pesch V, Amato MP, Iuliano G, Slee M, Verheul F, Cristiano E, Fernández-Bolaños R, Poehlau D, Saladino ML, Deri N, Cabrera-Gomez J, Vella N, Herbert J, Skromne E, Savino A, Shaw C, Moore F, Vucic S, Petkovska-Boskova T, McDonnell G, Hawkins S, Kee F, Butzkueven H; MSBase study group.

Mult Scler. 2014 May;20(6):739-46. doi: 10.1177/1352458513507816. Epub 2013 Oct 9.

PMID:
24107309
17.

Cyst formation and faecal-oral transmission of Dientamoeba fragilis--the missing link in the life cycle of an emerging pathogen.

Munasinghe VS, Vella NG, Ellis JT, Windsor PA, Stark D.

Int J Parasitol. 2013 Oct;43(11):879-83. doi: 10.1016/j.ijpara.2013.06.003. Epub 2013 Jul 19.

PMID:
23872523
18.

How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?

Fazekas F, Bajenaru O, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kobys T, Kraus J, Kurča E, Kyriakides T, Lisý L, Milanov I, Nehrych T, Moskovko S, Panayiotou P, Jazbec SŠ, Sokolova L, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Voloshyná N, Havrdová E.

Front Neurol. 2013 May 1;4:10. doi: 10.3389/fneur.2013.00010. eCollection 2013.

19.

The impact of shifting vantage perspective when recalling and imagining positive events.

Vella NC, Moulds ML.

Memory. 2014;22(3):256-64. doi: 10.1080/09658211.2013.778292. Epub 2013 Mar 22.

PMID:
23521317
20.

IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients.

Malaponte G, Polesel J, Candido S, Sambataro D, Bevelacqua V, Anzaldi M, Vella N, Fiore V, Militello L, Mazzarino MC, Libra M, Signorelli SS.

Cytokine. 2013 Apr;62(1):64-9. doi: 10.1016/j.cyto.2013.02.017. Epub 2013 Mar 11.

PMID:
23490413
21.

Adaptive Associations between Social Cognition and Emotion Regulation are Absent in Schizophrenia and Bipolar Disorder.

Rowland JE, Hamilton MK, Vella N, Lino BJ, Mitchell PB, Green MJ.

Front Psychol. 2013 Jan 11;3:607. doi: 10.3389/fpsyg.2012.00607. eCollection 2012.

22.

Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.

Fazekas F, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kraus J, Kurča E, Kyriakides T, Lisý L, Milanov I, Panayiotou P, Jazbec SS, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Havrdová E.

Wien Med Wochenschr. 2012 Aug;162(15-16):354-66. Epub 2012 Aug 16. Review. Erratum in: Wien Med Wochenschr. 2013 May;163(9-10):251. Multiple author names added.

23.

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome.

Meyniel C, Spelman T, Jokubaitis VG, Trojano M, Izquierdo G, Grand'Maison F, Oreja-Guevara C, Boz C, Lugaresi A, Girard M, Grammond P, Iuliano G, Fiol M, Cabrera-Gomez JA, Fernandez-Bolanos R, Giuliani G, Lechner-Scott J, Cristiano E, Herbert J, Petkovska-Boskova T, Bergamaschi R, van Pesch V, Moore F, Vella N, Slee M, Santiago V, Barnett M, Havrdova E, Young C, Sirbu CA, Tanner M, Rutherford M, Butzkueven H; MSBasis Study Group.

PLoS One. 2012;7(6):e38661. doi: 10.1371/journal.pone.0038661. Epub 2012 Jun 29.

24.

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.

Hughes S, Spelman T, Trojano M, Lugaresi A, Izquierdo G, Grand'maison F, Duquette P, Girard M, Grammond P, Oreja-Guevara C, Hupperts R, Boz C, Bergamaschi R, Giuliani G, Rio ME, Lechner-Scott J, van Pesch V, Iuliano G, Fiol M, Verheul F, Barnett M, Slee M, Herbert J, Kister I, Vella N, Moore F, Petkovska-Boskova T, Shaygannejad V, Jokubaitis V, McDonnell G, Hawkins S, Kee F, Gray O, Butzkueven H; MSBase Study Group.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):305-10. doi: 10.1136/jnnp-2011-301051. Epub 2011 Dec 28.

PMID:
22205675
25.
26.

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude.

Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M, Grand'Maison F, Gomez JA, Izquierdo G, Duquette P, Girard M, Grammond P, Oreja-Guevara C, Hupperts R, Bergamaschi R, Boz C, Giuliani G, van Pesch V, Iuliano G, Fiol M, Cristiano E, Verheul F, Saladino ML, Slee M, Barnett M, Deri N, Flechter S, Vella N, Shaw C, Herbert J, Moore F, Petkovska-Boskova T, Jokubaitis V, Butzkueven H; MSBase study group.

Mult Scler. 2012 Jul;18(7):974-82. doi: 10.1177/1352458511431729. Epub 2011 Dec 20.

PMID:
22185806
27.

Demyelination during anti-TNFα therapy for ankylosing spondylitis.

Mercieca C, Vella N, Borg AA.

Mod Rheumatol. 2012 Apr;22(2):303-7. doi: 10.1007/s10165-011-0498-4. Epub 2011 Jul 12.

PMID:
21748364
28.

'Genetic profiling' and ovarian cancer therapy (review).

Vella N, Aiello M, Russo AE, Scalisi A, Spandidos DA, Toffoli G, Sorio R, Libra M, Stivala F.

Mol Med Rep. 2011 Sep-Oct;4(5):771-7. doi: 10.3892/mmr.2011.512. Epub 2011 Jun 17. Review.

PMID:
21687948
29.

Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).

Aiello M, Vella N, Cannavò C, Scalisi A, Spandidos DA, Toffoli G, Buonadonna A, Libra M, Stivala F.

Mol Med Rep. 2011 Mar-Apr;4(2):203-8. doi: 10.3892/mmr.2010.408. Epub 2010 Dec 16. Review.

PMID:
21468552
30.

Haemocyte morphology and function in the Akoya pearl oyster, Pinctada imbricata.

Kuchel RP, Raftos DA, Birch D, Vella N.

J Invertebr Pathol. 2010 Sep;105(1):36-48. doi: 10.1016/j.jip.2010.04.011. Epub 2010 May 8.

PMID:
20457162
31.

Phagocytosis of the protozoan parasite, Marteilia sydneyi, by Sydney rock oyster (Saccostrea glomerata) hemocytes.

Kuchel RP, Aladaileh S, Birch D, Vella N, Raftos DA.

J Invertebr Pathol. 2010 Jun;104(2):97-104. doi: 10.1016/j.jip.2010.02.001. Epub 2010 Feb 11.

PMID:
20153334
32.
33.

Integration of evolutionary and desolvation energy analysis identifies functional sites in a plant immunity protein.

Casasoli M, Federici L, Spinelli F, Di Matteo A, Vella N, Scaloni F, Fernandez-Recio J, Cervone F, De Lorenzo G.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7666-71. doi: 10.1073/pnas.0812625106. Epub 2009 Apr 16.

34.

Uterine cervical carcinoma: role of matrix metalloproteinases (review).

Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA, Mazzarino C.

Int J Oncol. 2009 Apr;34(4):897-903. Review.

PMID:
19287946
35.
36.

Paraneoplastic cerebellar ataxia due to burnt-out testicular germ cell tumour?

van de Warrenburg BP, Rodriguez-Justo M, Vella NR, Freeman A, Bhatia KP, Quinn NP.

Eur Neurol. 2007;57(3):178-81. Epub 2007 Jan 11. No abstract available.

PMID:
17218768
37.

Reductions of Rubisco activase by antisense RNA in the C4 plant Flaveria bidentis reduces Rubisco carbamylation and leaf photosynthesis.

von Caemmerer S, Hendrickson L, Quinn V, Vella N, Millgate AG, Furbank RT.

Plant Physiol. 2005 Feb;137(2):747-55. Epub 2005 Jan 21.

38.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
39.

Multiple sclerosis in Malta in 1999: an update.

Dean G, Elian M, de Bono AG, Asciak RP, Vella N, Mifsud V, Aquilina J.

J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):256-60.

40.

Neuroimaging criteria for vascular dementia.

Pullicino P, Benedict RH, Capruso DX, Vella N, Withiam-Leitch S, Kwen PL.

Arch Neurol. 1996 Aug;53(8):723-8. Erratum in: Arch Neurol 1996 Nov;53(11):1146.

PMID:
8759977
41.

Electrophysiological and microiontophoretic analysis of the habenulo-hippocampal circuit.

Montalbano ME, Sabatino M, Zagami MT, Ferraro G, Caravaglios G, Vella N, La Grutta V.

Arch Int Physiol Biochim Biophys. 1991 Jun;99(3):275-9.

PMID:
1717065
42.

Dopaminergic control of feline hippocampal epilepsy: a nigro hippocampal pathway.

Ferraro G, Vella N, Sardo P, Caravaglios G, Sabatino M, La Grutta V.

Neurosci Lett. 1991 Feb 11;123(1):41-4.

PMID:
2062453
43.

A feature of caudate control of focal hippocampal epilepsy: evidence for an anterograde pathway.

Vella N, Ferraro G, Caravaglios G, Aloisio A, Sabatino M, La Grutta V.

Exp Brain Res. 1991;85(1):240-2.

PMID:
1884762
44.

Nigral influence on focal epilepsy.

Sabatino M, Ferraro G, Vella N, La Grutta V.

Neurophysiol Clin. 1990 Sep;20(3):189-201.

PMID:
2122206
45.

Habenular effect on hippocampal excitability is not cholinergically-mediated.

Zagami MT, Montalbano ME, Sabatino M, Ferraro G, Vella N, La Grutta V.

Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:41-2. No abstract available.

PMID:
2633183
46.

Neurotransmitters involved in the habenular control of raphe-hippocampal circuit.

Michele S, Vella N, Ferraro G, Gravante G, La Grutta V.

Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:39-40. No abstract available.

PMID:
2576686
47.

Striatonigral suppression of focal hippocampal epilepsy.

Sabatino M, Gravante G, Ferraro G, Vella N, La Grutta G, La Grutta V.

Neurosci Lett. 1989 Apr 10;98(3):285-90.

PMID:
2498786
48.

[Neurophysiologic study of the influence of the habenula on the hippocampus: electroencephalographic aspects].

Sabatino M, Gravante G, Vella N, Sardo P, Caravaglios G, La Grutta V.

Riv Neurol. 1989 Mar-Apr;59(2):77-82. Italian.

PMID:
2772512
49.

An electrophysiological study of habenular influence on hippocampus.

Sabatino M, Ferraro G, Vella N, La Grutta V.

Neurosci Lett. 1987 Jul 9;78(1):75-9.

PMID:
3614774
50.

[A possible functional circuit of striatal control of hippocampal epilepsy].

Sabatino M, Morici G, Ferraro G, Savatteri V, Vella N, La Grutta V.

Boll Soc Ital Biol Sper. 1987 Mar 31;63(3):253-8. Italian. No abstract available.

PMID:
3115282

Supplemental Content

Support Center